Wikidata

(Q53317535)

English

Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.

scientific article published in March 2011

In more languages

Statements

title
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21414558
retrieved
13 May 2018
reference URL
http://europepmc.org/abstract/MED/21414558

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53317535&oldid=2102433084"